NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MRK

Merck & Co Inc

May 23 • 10:27AM ET

77.37

Dollar change -0.47
Percentage change -0.60	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE AZN NVS BMY JNJ AMGN ABBV GSK LLY SNY

| Held by: VTI VOO SCHD SPY IVV VTV XLV VIG VYM IWF

Scroll to Statements

Index	DJIA, S&P 500	P/E	11.26	EPS (ttm)	6.87	Insider Own	0.07%	Shs Outstand	2.52B	Perf Week	1.72%
Market Cap	194.28B	Forward P/E	7.96	EPS next Y	9.72	Insider Trans	-0.19%	Shs Float	2.51B	Perf Month	-3.09%
Income	17.43B	PEG	0.97	EPS next Q	2.06	Inst Own	80.26%	Short Float	1.48%	Perf Quarter	-15.23%
Sales	63.78B	P/S	3.05	EPS this Y	16.40%	Inst Trans	1.32%	Short Ratio	2.22	Perf Half Y	-19.86%
Book/sh	19.21	P/B	4.03	EPS next Y	9.16%	ROA	15.78%	Short Interest	37.14M	Perf Year	-40.83%
Cash/sh	3.72	P/C	20.82	EPS next 5Y	11.66%	ROE	39.31%	52W Range	73.31 - 134.63	Perf YTD	-22.23%
Dividend Est.	3.14 (4.06%)	P/FCF	11.40	EPS past 5Y	12.04%	ROI	21.31%	52W High	-42.53%	Beta	0.41
Dividend TTM	3.16 (4.08%)	Quick Ratio	1.16	Sales past 5Y	7.14%	Gross Margin	74.68%	52W Low	5.54%	ATR (14)	2.35
Dividend Ex-Date	Mar 17, 2025	Current Ratio	1.41	EPS Y/Y TTM	654.93%	Oper. Margin	34.71%	RSI (14)	44.92	Volatility	1.26% 2.69%
Employees	75000	Debt/Eq	0.72	Sales Y/Y TTM	4.40%	Profit Margin	27.33%	Recom	1.88	Target Price	102.68
Option/Short	Yes / Yes	LT Debt/Eq	0.69	EPS Q/Q	7.20%	Payout	46.32%	Rel Volume	0.58	Prev Close	77.84
Sales Surprise	1.24%	EPS Surprise	4.09%	Sales Q/Q	-1.20%	Earnings	Apr 24 BMO	Avg Volume	16.72M	Price	77.37
SMA20	-2.25%	SMA50	-6.43%	SMA200	-21.16%	Trades		Volume	1,821,092	Change	-0.60%

Date	Action	Analyst	Rating Change	Price Target Change
May-14-25	Downgrade	Citigroup	Buy → Neutral	$84
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$85
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130
Mar-28-23	Downgrade	Societe Generale	Buy → Hold
Mar-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $115

Show Previous Ratings

Today 10:15AM	Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics (Investor's Business Daily)
08:16AM	Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More (Zacks)
May-22-25 08:46AM	CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success (Zacks)
07:15AM	Moderna Stock Looks Ripe for a Short Squeeze (MarketBeat)
06:45AM	Merck to Participate in the Bernstein 41st Annual Strategic Decisions Conference (Business Wire)
11:28AM	Loading…
May-21-25 11:28AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
09:05AM	AstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip? (Zacks)
May-20-25 10:22AM	MRK, Daiichi Begin Pivotal Esophageal Cancer Study With ADC Drug (Zacks)
08:46AM	Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech (Zacks)
May-19-25 09:51AM	The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie (Zacks)
08:29AM	PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now? (Zacks)
07:00AM	IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (Business Wire)
06:20AM	Is Invesco Dow Jones Industrial Average Dividend ETF (DJD) a Strong ETF Right Now? (Zacks)
May-18-25 08:31PM	The Top Corporate Board Directors (The Wall Street Journal)
May-16-25 08:06AM	Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals (Zacks)
06:45AM	Loading…
06:45AM	Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Societys (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension (Business Wire)
May-15-25 03:26PM	FDA awards cancer drug approvals to AbbVie and MSD (Pharmaceutical Technology)
12:05PM	FDA approves Mercks belzutifan for pheochromocytoma or paraganglioma (TipRanks)
10:46AM	Jefferies not seeing significant impact to Merck, Bristol from draft guidance (TipRanks)
06:45AM	Merck Announces Phase 3 KEYNOTE-B96 Trial Met Primary Endpoint of Progression-Free Survival (PFS) in Patients With Platinum-Resistant Recurrent Ovarian Cancer Whose Tumors Expressed PD-L1 and in All Comers (Business Wire)
06:17AM	The Zacks Analyst Blog Highlights Oracle, IBM, Merck and Earth Science Tech (Zacks)
May-14-25 07:56PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
06:44PM	Top Analyst Reports for Oracle, IBM & Merck (Zacks)
05:15PM	FDA Approves Mercks WELIREG (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (PPGL) (Business Wire)
03:17PM	FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors (Benzinga)
11:31AM	3 Absurdly Cheap Stocks Trading Near Their 52-Week Lows (Motley Fool)
May-13-25 05:06PM	Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom? (Insider Monkey)
09:22AM	The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen (Zacks)
07:36AM	Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared (Zacks)
06:45AM	Research on Novel Treatment Approaches and Scientific Advances From Mercks Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025 (Business Wire)
06:43AM	Loading…
06:43AM	Zacks Investment Ideas feature highlights: Alibaba, JD.com, SPDR S&P Biotech ETF, Merck and Microsoft (Zacks)
May-12-25 07:20PM	Trump's drug price order is part request, part threat: Analyst (Yahoo Finance Video) +5.87%
04:56PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
03:50PM	How Trump could go about executing order to slash drug prices (Yahoo Finance Video)
03:05PM	Merck & Co., Inc. (MRK): One of the Worst Blue Chip Stocks to Buy (Insider Monkey)
12:34PM	Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order (Yahoo Finance)
10:01AM	Mag 7 rally, airline & pharmaceutical stocks: Trending Tickers (Yahoo Finance Video)
09:37AM	Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug Costs (Zacks)
08:58AM	Surprise Breakthrough: US-China Talks Spark Market Rally (Zacks)
04:28AM	Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices (Bloomberg)
May-10-25 04:10AM	Is Merck & Co., Inc. (MRK) the Best Income Stock to Invest in Now? (Insider Monkey)
May-09-25 12:35AM	1 Healthcare Stock to Consider Right Now and 2 to Brush Off (StockStory)
May-08-25 11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
09:12AM	2 Beaten-Down Stocks That Are Great Buys on the Dip (Motley Fool)
06:45AM	Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto (Business Wire)
May-07-25 04:55PM	Is Merck & Co., Inc. (MRK) the Best Dow Stock? (Insider Monkey)
04:51PM	Trump planning on Executive Order to further cut Medicare drug prices - report (Seeking Alpha)
11:06AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
09:26AM	Stock Market News for May 7, 2025 (Zacks)
08:25AM	Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli's Large-Cap Stock Picks with Huge Upside Potential (Insider Monkey)
06:45AM	Merck to Participate in the Bank of America 2025 Global Healthcare Conference (Business Wire)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-06-25 11:42AM	Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck (Investor's Business Daily)
09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)
May-05-25 11:00AM	Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now? (Insider Monkey)
07:42AM	Franklin Income SMA Q1 2025 Commentary (Seeking Alpha)
06:20AM	Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar? (Zacks)
05:06AM	I Scanned The S&P 500 For GARP Stocks; Here's What I Found (Seeking Alpha)
May-03-25 09:46AM	Dogs Of The Dow Chase May's 'Safer' Buy (Seeking Alpha)
08:30AM	5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (May 2025) (Seeking Alpha)
04:15AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
May-02-25 10:00AM	Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (Seeking Alpha)
09:01AM	Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil (Zacks)
05:07AM	Inhibikase Therapeutics: A Hold With Uncertain Prospects In PAH (Seeking Alpha)
May-01-25 10:23PM	Top 10 High-Yield Dividend Stocks To Consider In May 2025 (Seeking Alpha)
05:23PM	Merck & Co., Inc. (MRK): Jim Cramer Agrees - "Merck's A Good Company" (Insider Monkey)
11:51AM	LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down (Zacks)
11:22AM	Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts (Zacks)
09:06AM	Halozyme Therapeutics: Still Undervalued Ahead Of Earnings (Seeking Alpha)
09:00AM	Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know (Zacks)
08:00AM	Arvinas, Entrada cut staff; Merck builds US hub for Keytruda (BioPharma Dive)
Apr-30-25 02:25PM	Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months? (Insider Monkey)
11:18AM	Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness' Stock Picks with Huge Upside Potential (Insider Monkey)
10:00AM	Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now (Motley Fool)
09:09AM	Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss? (Zacks)
05:41AM	Construction begins on MSDs $1bn biologics centre in Delaware, US (Pharmaceutical Technology)
05:17AM	3 Names I Picked Up In The Latest Market Slump (Seeking Alpha)
Apr-29-25 12:11PM	How To Put $100 In Your Retirement Fund Each Month With Merck Stock (Benzinga)
10:31AM	Pfizer offers 'longer-term' opportunity amid tariff uncertainty (Yahoo Finance Video)
10:27AM	Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025? (Insider Monkey)
09:42AM	Stocks to Watch Tuesday: UPS, Spotify, PayPal, BP (The Wall Street Journal)
09:12AM	AZN Q1 Earnings Beat, Stock Down on Soft Sales Performance of Key Drugs (Zacks)
06:45AM	Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware (Business Wire)
05:30AM	Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug (The Wall Street Journal)
Apr-28-25 12:17PM	Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion (Benzinga)
11:16AM	Jim Cramer Says Merck & Co (MRK) Has 'Turned Into a Complete Nightmare' (Insider Monkey)
10:35AM	Temu, Tesla prices, Merck KGaA deal: Trending Tickers (Yahoo Finance Video)
09:19AM	Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now? (READY TO EDIT2) (Insider Monkey)
09:19AM	Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now? (Insider Monkey)
09:18AM	BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
08:31AM	2 Must-Own Dividends At Bargain Basement Prices (Seeking Alpha)
07:48AM	Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat? (Zacks)
03:07AM	Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-27-25 03:08PM	Merck & Co., Inc. (MRK): Among Billionaire Ken Fisher's Healthcare Stock Picks with Massive Upside Potential (Insider Monkey)
12:00PM	KEYTRUDA (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (Business Wire)
09:22AM	Immunocore Holdings: A Name On My Watch List (Seeking Alpha)
07:00AM	Wall Streets New Tariff Safe Haven: High-Tax Biotech Stocks (The Wall Street Journal)
Apr-26-25 02:32PM	2 Outstanding Dividend Stocks to Buy and Hold For 20 Years (Motley Fool)
12:50PM	Akeso survival data for ivonescimab misses expectations, STAT says (TipRanks)
09:30AM	Summit Therapeutics: New Ivonescimab Data Raise Concerns (Seeking Alpha)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smart Dalton E. III	SVP Fin. - Global Controller	May 03 '25	Option Exercise	83.18	2,050	170,519	10,127	May 05 04:23 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 30 '25	Option Exercise	84.71	464	39,305	8,242	May 02 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	May 02 '25	Option Exercise	83.26	381	31,722	8,464	May 02 04:18 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '25	Option Exercise	83.26	2,262	188,334	24,061	May 02 04:14 PM
Romanelli Joseph	President, Human Health Int?l	Apr 30 '25	Option Exercise	84.71	2,063	174,757	22,816	May 02 04:14 PM
Larson Betty D	EVP, Chief HR Officer	Apr 30 '25	Option Exercise	84.71	11,350	961,458	11,350	May 02 04:12 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Option Exercise	58.08	5,000	290,400	12,040	Apr 29 04:04 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Sale	82.76	4,262	352,723	7,778	Apr 29 04:04 PM
DALTON SMART	Officer	Apr 25 '25	Proposed Sale	82.76	4,262	352,723		Apr 25 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 08 '25	Option Exercise	87.28	13,002	1,134,815	45,609	Feb 11 02:59 PM
THULIN INGE G	Director	Feb 06 '25	Buy	88.25	2,833	250,000	2,933	Feb 07 04:09 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Feb 06 '25	Sale	88.76	2,361	209,551	7,085	Feb 07 04:07 PM
BAKER DOUGLAS M JR	Director	Feb 05 '25	Buy	88.50	15,000	1,327,500	16,000	Feb 07 04:04 PM
CRISTAL DOWNING	Officer	Feb 06 '25	Proposed Sale	88.76	2,361	209,551		Feb 06 04:43 PM
Guindo Chirfi	Chief Marketing Officer	Aug 05 '24	Option Exercise	115.20	36,901	4,250,995	57,782	Aug 06 12:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRK

Merck & Co Inc

Upgrade your FINVIZ experience